Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.
作者信息
Lazarus Jeffrey V, Lundgren Jens, Casabona Jordi, Wiessing Lucas, Matheï Catharina, Vickerman Peter, Prins Maria, Kretzschmar Mirjam, Kantzanou Maria, Giraudon Isabelle, Ferri Marica, Griffiths Paul, Harris Magdalena, Walker Margaret, Chavdarova Lilyana, Schatz Eberhard, Schiffer Katrin, Kools John, Farell Jason, Mendão Luís
出版信息
BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S18. doi: 10.1186/1471-2334-14-S6-S18. Epub 2014 Sep 19.
Abstract
摘要
相似文献
1
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.圆桌讨论：从艾滋病中学到的经验教训如何为全球应对病毒性肝炎提供借鉴。
BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S18. doi: 10.1186/1471-2334-14-S6-S18. Epub 2014 Sep 19.
2
[Accidental exposure to blood].[意外接触血液]
Ann Dermatol Venereol. 1997;124(12):873-7.
3
Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001-2005.2001 - 2005年欧盟注射吸毒者中持续存在的艾滋病毒和病毒性肝炎感染情况。
Euro Surveill. 2006 Nov 23;11(11):E061123.2. doi: 10.2807/esw.11.47.03084-en.
4
[Viral hepatitis B and C: an object of public health research].
Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S1-1S3.
5
HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.东欧地区的艾滋病毒/肝炎合并感染以及泛欧洲预防和管理肝炎的新方法。
Int J Drug Policy. 2007 Oct;18(5):426-32. doi: 10.1016/j.drugpo.2007.01.011. Epub 2007 Feb 15.
6
Inmates in Irish prisons face drug abuse and disease.
Lancet. 1999 Aug 28;354(9180):753. doi: 10.1016/S0140-6736(05)76001-3.
7
Bloodborne pathogen transmission in health care workers. Risks and prevention strategies.医护人员中的血源性病原体传播。风险与预防策略。
Infect Dis Clin North Am. 1997 Jun;11(2):331-46. doi: 10.1016/s0891-5520(05)70359-7.
8
9
Hepatitis - a devastating epidemic in Europe.肝炎——欧洲一场毁灭性的流行病。
BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S1. doi: 10.1186/1471-2334-14-S6-S1. Epub 2014 Sep 19.
10
Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.静脉注射吸毒者尸检材料中多种肝炎病毒感染的证据。
Ig Sanita Pubbl. 2005 Sep-Oct;61(5):435-50.
引用本文的文献
1
The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data.Hep-CORE 政策评分：基于患者组织数据的欧洲丙型肝炎国家政策实施排名。
PLoS One. 2020 Jul 28;15(7):e0235715. doi: 10.1371/journal.pone.0235715. eCollection 2020.
2
Hepatitis B prevention: Can we learn from the response to HIV/AIDS?乙型肝炎预防：我们能否从应对艾滋病的经验中吸取教训？
PLoS Med. 2020 Apr 21;17(4):e1003109. doi: 10.1371/journal.pmed.1003109. eCollection 2020 Apr.
3
Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.基于证据的干预措施，以加强慢性丙型肝炎护理连续过程中的评估、治疗和依从性。
Int J Drug Policy. 2015 Oct;26(10):922-35. doi: 10.1016/j.drugpo.2015.05.002. Epub 2015 May 17.
本文引用的文献
1
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.欧洲注射吸毒者中的丙型肝炎病毒感染流行病学：扩大治疗与预防规模的数据系统评价
PLoS One. 2014 Jul 28;9(7):e103345. doi: 10.1371/journal.pone.0103345. eCollection 2014.
2
Can hepatitis C virus infection be eradicated in people who inject drugs?注射毒品的人丙型肝炎病毒感染能被根除吗？
Antiviral Res. 2014 Apr;104:62-72. doi: 10.1016/j.antiviral.2014.01.002. Epub 2014 Jan 24.
3
Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe?人群中人类免疫缺陷病毒（艾滋病毒）：欧洲的风险在增加吗？
Euro Surveill. 2013 Nov 28;18(48):20648. doi: 10.2807/1560-7917.es2013.18.48.20648.
4
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).在欧洲，HIV 阳性者延迟就诊的风险因素和结果：来自合作观察性 HIV 流行病学研究欧洲研究（COHERE）的结果。
PLoS Med. 2013;10(9):e1001510. doi: 10.1371/journal.pmed.1001510. Epub 2013 Sep 3.
5
Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.世卫组织欧洲区域乙型和丙型肝炎感染的流行情况和估计数：重点审查欧盟和欧洲自由贸易联盟以外国家的数据。
Epidemiol Infect. 2014 Feb;142(2):270-86. doi: 10.1017/S0950268813000940. Epub 2013 May 29.
6
Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?HCV-HIV 双重感染在注射吸毒者中的流行率是否是衡量性传播和注射相关 HIV 传播水平的一个指标？
Drug Alcohol Depend. 2013 Sep 1;132(1-2):172-81. doi: 10.1016/j.drugalcdep.2013.01.020. Epub 2013 Feb 28.
7
Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).指标性疾病导向检测用于 HIV 的可行性和有效性：来自 HIDES I（全欧 HIV 指标性疾病研究）的结果。
PLoS One. 2013;8(1):e52845. doi: 10.1371/journal.pone.0052845. Epub 2013 Jan 15.
8
HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.基线时从未注射过海洛因的吸毒者中 HCV 血清转换：除开始注射外，未发现其他预测因素。
Int J Drug Policy. 2012 Sep;23(5):415-9. doi: 10.1016/j.drugpo.2012.02.002. Epub 2012 Mar 14.
9
10
Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.2005 年至 2010 年期间，欧洲注射吸毒者中的 HIV 和丙型肝炎病毒感染趋势。
Euro Surveill. 2011 Dec 1;16(48):20031.
Zotero 插件